Imcyse is a biopharmaceutical company that develops immunotherapies for the treatment and prevention of severe chronic diseases. It offers Imotopes, a platform that blocks the immune responses that cause immune-mediated diseases. Its therapeutic area includes diabetes, neuromyelitis optica, rheumatoid arthritis, celiac disease, etc.